Michigan expands antibody treatment to cut hospitalizations

by on

The drugs, delivered intravenously and made by Regeneron Pharmaceuticals and Eli Lily, have concentrated doses of lab-made antibodies to fight COVID-19 and are geared toward people who are at high risk for severe symptoms or having to be hospitalized.

The drugs, delivered intravenously and made by Regeneron Pharmaceuticals and Eli Lily, have concentrated doses of lab-made antibodies to fight COVID-19 and are geared toward people who are at high risk for severe symptoms or having to be hospitalized.

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: